Abstract
The human major histocompatibility complex (MHC), or HLA (for human leukocyte antigen), is located on chromosome 6 and contains multiple genes that encode proteins which play central roles in the generation of immune responses. The HLA complex can be divided into three regions, each of which contains genes that encode molecules of similar structures: the class I and II genes encode the HLA class I and II molecules, respectively, and the class III genes encode the C4, C2, and Bf components of the complement system. The HLA class I and II molecules are intimately involved in the process of discriminating self from non-self, and these molecules share the characteristic of being highly polymorphic in the population.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Selected References
Astorga GP, Williams RC. Altered reactivity in mixed lymphocyte culture of lymphocytes from patients with rheumatoid arthritis. Arthritis Rheum 1969; 12: 547–554.
Bjorkman PJ, Parham, P. Structure, function, and diversity of class I major histocompatibility complex molecules. Annu Rev Biochem 1990; 59: 253–288.
Bjorkman PJ, Saper MA, Samraoui B, Bennett WS, Strominger JL, Wiley DC. Structure of the human class I histocompatibility antigen, HLA-A2. Nature 1987; 32: 506–512.
Bjorkman PJ, Saper MA, Samraoui B, Bennett WS, Strominger JL, Wiley DC. The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens. Nature 1987; 329: 512–518.
Bodmer JG, Marsh GE, Albert ED, Bodmer WF, et al. Nomenclature for factors of the HLA system, 1995. Hum Immunol 1995; 43: 149–164.
Bodmer JG, Marsh SGE, Albert ED, et al. Nomenclature for factors of the HLA system, 1991. Hum Immunol 1992; 34: 4–18.
Brown JH, Jardetzky TS, Gorga JC, et al. Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature 1993; 364: 33–39.
Caillat-Zucman S, Garchon H-J, Timsit J, et al. Age-dependent HLA Genetic Heterogeneity of Type 1 insulin-dependent diabetes mellitus. J Clin Invest 1992; 90: 2242–2250.
Campbell RD, Trowsdale J. Map of the human MHC. Immunol Today 1993; 14: 349–352.
Fu X-T, Bono CP, Woulfe SL, et al. Pocket 4 of the HLA-DR(a,(31 *0401) molecule is a major determinant of T cell recognition of peptide. J Exp Med 1995; 181: 915–926.
Garrett TPJ, Saper MA, Bjorkman PJ, Strominger JL, Wiley DC. Specificity pockets for the side chains of peptide antigens in HLA-Aw68. Nature 1989; 342: 692–696.
Ghosh P, Amaya M, Mellins E, Wiley DC. The structure of an intermediate in class II maturation: CLIP bound to HLA-DR3. Nature 1995; 378: 457–462.
Gregersen PK, Silver J, Winchester RJ. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 1987; 30: 1205–1213.
Hammer J, Gallazzi F, Bono E, et al. Peptide binding specificity of HLA-DR4 molecules: Correlation with rheumatoid arthritis association. J Exp Med 1995; 181: 1847–1855.
Jardetzky T. Not just another Fab: the crystal structure of a TcR-MHCpeptide complex. Structure 1997; 5: 159–163.
Jonas BL, Gonzalez EB, Callahan L et al. The shared epitope is not associated with disease severity in an African-American population with rheumatoid arthritis. Arthritis Rheum 1995; 38: S193.
Madden DR, Gorga JC, Strominger JL, Wiley DC. The structure of HLA-B27 reveals nonamer self-peptides bound in an extended conformation. Nature 1991; 353: 321–325.
McDaniel DO, Alarcon GS, Pratt PW, Reveille JD. Most African-American patients with rheumatoid arthritis do not have the rheumatoid antigenic determinant (epitope). Ann Intern Med 1995; 123: 181–187.
Nepom GT. Immunogenetics and IDDM. Diabetes Rev 1993; 1: 93–103.
Olsen NJ, Callahan LF, Brooks RM et al. Associations of HLA-DR4 with rheumatoid factor and radiographic severity in rheumatoid arthritis. Am J Med 1988; 84: 257–264.
Rammensee H-G, Friede T, Stevanovic S. MHC ligands and peptide motifs: first listing. Immunogenetics 1995; 41: 178–228.
Schlosstein L, Terasaki PI, Bluestone R, Pearson CM. High association of an HL-A antigen, W27, with ankylosing spondylitis. N Engl J Med 1973; 288: 704–706.
Schwartz BD. Infectious agents, immunity, and rheumatic diseases. Arthritis Rheum 1990; 33: 457–465.
Stastny P. Mixed lymphocyte cultures in rheumatoid arthritis. J Clin Invest 1976; 57: 1148–1157.
Stastny P. Association of the B-cell alloantigen DRw4 with rheumatoid arthritis. N Engl J Med 1978; 298: 869–871.
Stern LJ, Brown JH, Jardetzky TS, et al. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 1994; 368: 215–221.
Tiwara JL, Terasaki PI. HLA and Disease Associations. New York: Springer-Verlag;1985.
Todd JA, Bell JI, McDevitt HO. HLA-DQ(3 gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 1987; 329: 599–604.
Weyand CM, Hicok KC, Conn DL, Goronzy JJ. The influence of HLA-DRB 1 genes on disease severity in rheumatoid arthritis. Ann Intern Med 1992; 117: 801–806.
Weyand CM, McCarthy TG, Goronzy JJ. Correlation between disease phenotype and genetic heterogeneity in rheumatoid arthritis. J Clin Invest 1995; 95: 2120–2126.
Weyand CM, Xie C, Goronzy JJ. Homozygosity for the HLA-DRB 1 allele selects for extraarticular manifestations in rheumatoid arthritis. J Clin Invest 1992; 89: 2033–2039.
Wordsworth P, Pile KD, Buckely JD, et al. HLA heterozygosity contributes to susceptibility to rheumatoid arthritis. Am J Hum Genet 1992; 51: 585–591.
Wucherpfenning KW, Strominger JL. Selective binding of self peptides to disease-associated major histocompatibility complex (MHC) molecules: a mechanism for MHC-linked susceptibility to human autoimmune diseases. J Exp Med 1995; 181: 1597–1601.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media New York
About this chapter
Cite this chapter
Karr, R.W. (1998). The HLA Complex. In: Jameson, J.L. (eds) Principles of Molecular Medicine. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-726-0_31
Download citation
DOI: https://doi.org/10.1007/978-1-59259-726-0_31
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-4757-6272-3
Online ISBN: 978-1-59259-726-0
eBook Packages: Springer Book Archive